Browsing by Subject

A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer

Solomon, Benjamin; Callejo Perez, Ana; Bar, Jair; Berchem, Guy; Bazhenova, Lyudmila; Saintigny, Pierre; Felip Font, Enriqueta (Wiley, 2022-07)

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Harbeck, Nadia; Rastogi, P.; Martin, M.; Tolaney, Sara M; Shao, Zhi Min; Fasching, Peter A.; Cortés Castan, Javier (Elsevier, 2021-12)

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report

Mirallas Viñas, Oriol; Filippi Arriaga, Maria Francesca Eugenia; Hernández Hernández, Irene; Aubanell, Anton; Chaachou, Anas; Garcia-Alvarez, Alejandro; Hernando Cubero, Jorge; Martinez Saez, Elena Antima; Biagetti Biagetti, Betina; Capdevila Castillon, Jaume (Frontiers Media, 2021-11-11)

Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer

Schettini, Francesco; Giuliano, Mario; Lambertini, Matteo; Bartsch, Rupert; Pinato, David James; Onesti, Concetta Elisa; Cortés Castan, Javier (MDPI, 2021-09)

Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer

Awada, Ahmad; Boni, Valentina; Moreno, Victor; Aftimos, Philippe; Kahatt, Carmen; Luepke Estefan, Xarles Erik; Tabernero Caturla, Josep (Elsevier, 2022-12)

Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial

Chibaudel, Benoist; Henriques, Julie; Rakez, Manel; Brenner, Baruch; Kim, Tae Won; Martínez-Villacampa, Mercedes; Tabernero Caturla, Josep (American Medical Association, 2020-10-19)

Axicabtagen ciloleucel i tisagenlecleucel per al tractament del limfoma B de cèl·lules grans

Programa d'Harmonització Farmacoterapèutica (Servei Català de la Salut, 2019-03-21)

Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study

de Wit, R.; Wülfing, C.; Castellano, D.; Kramer, G.; Eymard, J.-C.; Sternberg, C. N.; Carles Galceran, Joan (Elsevier, 2021-10)

Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer

Saura Manich, Cristina; Matito Ariza, Judit; Antunes de Melo Oliveira, Ana Mafalda; Wildiers, Hans; Brufksy, Adam M.; Waters, Simon; Vivancos Prellezo, Ana (American Association for Cancer Research, 2021-11-01)

Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study

Felip Font, Enriqueta; de Braud, Filippo G.; Maur, Michela; Loong, Herbert H.; Shaw, Alice Tsang; Vansteenkiste, Johan F. (Elsevier, 2020-03)

Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma

Garcia-Alvarez, Alejandro; Ortiz Velez, Carolina; Muñoz Couselo, Eva (Dove Medical Press, 2021-06-09)

Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis

Tabernero Caturla, Josep; Argilés Martinez, Guillem; Sobrero, Alberto; Borg, Christophe; Ohtsu, Atsushi; Mayer, Robert (BMJ, 2020-08-19)

Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer

Angeles, Martina Aida; Cabarrou, Bastien; Gil Moreno, Antonio; Perez Benavente, Maria Asuncion; Spagnolo, Emanuela; Rychlik, Agnieszka (Korean Society of Gynecologic Oncology & Colposcopy, 2021-11)

Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer: results from an expansion cohort of a phase I study

Olmedo García, María Eugenia; Forster, Martin; Moreno, Victor; López-Criado, María Pilar; Braña Garcia, Irene; Flynn, Michael (Springer, 2021-10)

Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)

Shitara, Kohei; Doi, Toshihiko; Hosaka, Hisashi; Thuss-Patience, Peter; Santoro, Armando; Longo-Muñoz, Federico; Alsina Maqueda, Maria (Springer, 2022-05)

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial

Rugo, Hope; Im, Seock-Ah; Cardoso, Fatima; Cortés Castan, Javier; Curigliano, Giuseppe; Musolino, Antonio; Saura Manich, Cristina (American Medical Association, 2021-04)

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial

Hurvitz, Sara; Saura Manich, Cristina; Antunes de Melo Oliveira, Ana Mafalda; Trudeau, Maureen E.; Moy, Beverly; Delaloge, Suzette (Wiley, 2021-08)

EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer

Oaknin Benzaquen, Ana Mazaltob; Monk, Bradley J.; Vergote, Ignace; de Melo, Andreia Cristina; Kim, Yong-Man; Lisyanskaya, Alla (Elsevier, 2022-10)

Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design

Riely, Gregory; Ahn, Myung-Ju; Felip Font, Enriqueta; Ramalingam, Suresh; Smit, Egbert; Tsao, Anne (Future Medicine, 2022-03)

Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis

Swain, Sandra; Macharia, Harrison; Cortés Castan, Javier; Dang, Chau; Gianni, Luca; Hurvitz, Sara (MDPI, 2022-10-15)

Scientia. Dipòsit d'Informació Digital del Departament de Salut